The FDA has cleared Medtronic‘s (NYSE:MDT) Guardian sensor, part of the medtech titan’s MiniMed 670G automated insulin delivery system, to be worn on the upper arm.
The device is Medtronic’s newest and most accurate continuous glucose monitor, the company touted, and is the only sensor approved by the FDA for use with a hybrid-closed loop system to control insulin delivery.
Get the full story at our sister site, Drug Delivery Business News.
The post Medtronic wins sensor nod from FDA for MiniMed 670G auto insulin tech appeared first on MassDevice.